The 7-year course of depression and anxiety in the general population

Acta Psychiatrica Scandinavica

Volumn 123, Issue 4, 2011, Pages 297-306

  Rhebergen, D ^a   Batelaan, N M ^a,b   de Graaf, R ^b   Nolen, W A ^c   Spijker, J ^b,d   Beekman, A T F ^a   Penninx, B W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d De Gelderse Roos   (Netherlands)

Author keywords

Anxiety; Course; Depression; General population

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CHILDHOOD; CLINICAL EXAMINATION; COMORBIDITY; COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW; DEPRESSION; DISEASE DURATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LIFE CHART INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MENTAL HEALTH; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NETHERLANDS; NEUROSIS; PHYSICAL CAPACITY; POPULATION; PRIORITY JOURNAL; PROGNOSIS; SHORT FORM 36;

ADULT; ANXIETY DISORDERS; CHILD; CHILD ABUSE; CHRONIC DISEASE; COMORBIDITY; DEPRESSIVE DISORDER; HEALTH SURVEYS; HUMANS; MENTAL HEALTH; NETHERLANDS; NEUROTIC DISORDERS; PHYSICAL FITNESS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES;

EID: 79952240607     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01677.x     Document Type: Article

References (43)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EEL. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
2. Keller MB, Lavori PW, Mueller TI et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992;49:809-816.
3. Bruce SE, Yonkers KA, Otto MW et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005;162:1179-1187.
4. Keller MB, Krystal JH, Hen R et al. Untangling depression and anxiety: clinical challenges. J Clin Psychiatry 2005;66:1477-1484.
5. Angst J, Vollrath M. The natural history of anxiety disorders. Acta Psychiatr Scand 1991;84:446-452.
6. Fichter MM, Quadflieg N, Fischer UC, Kohlboeck G. Twenty-five-year course and outcome in anxiety and depression in the Upper Bavarian Longitudinal Community Study. Acta Psychiatr Scand 2010;122:75-85.
7. Preisig M, Merikangas KR, Angst J. Clinical significance and comorbidity of subthreshold depression and anxiety in the community. Acta Psychiatr Scand 2001;104:96-103.
8. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics 1946;3:47-53.
9. Murphy JM. Diagnostic comorbidity and symptom co-occurence: the Stirling County study. In: Maser JD, Cloninger CR, eds. Comorbidity of mood and anxiety disorders. Washington, DC: American Psychiatric Press Inc, 1990:153-176.
10. Merikangas KR, Zhang H, Avenevoli S et al. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry 2003;60:993-1000.
11. Vollrath M, Angst J. Outcome of panic and depression in a seven-year follow-up: results of the Zurich study. Acta Psychiatr Scand 1989;80:591-5969.
12. De Graaf R, Bijl RV, Smit F et al. Psychiatric and sociodemographic predictors of attrition in a longitudinal study: the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Am J Epidemiol 2000;152:1039-1047.
13. Penninx BW, Beekman AT, Smit JH et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008;17:121-140.
14. Bijl RV, Van Zessen G, Ravelli A, De Rijk C, Langendoen Y. The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol 1998;33:581-586.
15. Smeets RMW, Dingemans PMAJ. Composite International Diagnostic Interview (CIDI), version 1.1. Amsterdam/Geneva: World Health Organization, 1993.
16. World Health Organization. Composite International Diagnostic Interview (CIDI), version 2.1. Geneva: WHO, 1998.
17. Wittchen HU. Reliability and validity studies of the WHO - Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994;28:57-84.
18. Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry 1991;159:645-653.
19. Haro JM, Arbabzadeh-Bouchez S, Brugha TS et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int J Methods Psychiatr Res 2006;15:167-180.
20. Lyketsos C, Nestadt G, Cwi J et al. The life-chart interview: a standardized method to describe the course of psychopathology. Int J Methods Psychiatr Res 1994;4:143-155.
21. Van De Berg J, Van De Bos GAM. Het (meten van het) voorkomen van chronische aandoeningen 1974-1987. Maandber Gezondheid (CBS) 1989;8:4-21.
22. Aaronson NK, Muller M, Cohen PD et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51:1055-1068.
23. Mchorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
24. Mchorney CA, Ware JE Jr, Lu JF et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
25. SPSS. SPSS for Windows: version 15.0. Chicago: SPSS, 2006.
26. Tyrer P, Seivewright H, Johnson T. The Nottingham Study of Neurotic Disorder: predictors of 12-year outcome of dysthymic, panic and generalized anxiety disorder. Psychol Med 2004;34:1385-1394.
27. Angst J, Wicki W. The Zurich Study. XI. Is dysthymia a separate form of depression? Results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci 1991;240:349-354.
28. Hagnell O, Grasbeck A. Comorbidity of anxiety and depression in the Lundby 25-year prospective study: the pattern of subsequent episodes. In: Maser J, Cloninger CR, eds. Comorbidity of mood and anxiety disorders. Washington, DC: American Psychiatric Press Inc, 1990:139-152.
29. Kessler RC, Nelson CB, Mcgonagle KA, Lin J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996;30:17-30.
30. Sherbourne CD, Wells KB. Course of depression in patients with comorbid anxiety disorders. J Affect Disord 1997;43:245-250.
31. Merikangas KR, Angst J, Eaton W et al. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. Br J Psychiatry Suppl 1996;30:58-67.
32. Spijker J, Bijl RV, De Graaf R, Nolen WA. Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 2001;104:19-24.
33. Kendler KS, Kuhn J, Prescott CA. The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry 2004;161:631-636.
34. Rhebergen D, Beekman AT, De Graaf R et al. The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression. J Affect Disord 2009;115:450-459.
35. Beard JR, Galea S, Vlahov D. Longitudinal population-based studies of affective disorders: where to from here? BMC Psychiatry 2008;8:83.
36. Kuehner C, Huffziger S. Subjective quality of life aspects predict depressive symptoms over time: results from a three-wave longitudinal study. Acta Psychiatr Scand 2009;120:496-499.
37. Spijker J, De Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA. Determinants of persistence of major depressive episodes in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 2004;81:231-240.
38. Beekman AT, Bremmer MA, Deeg DJ et al. Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry 1998;13:717-726.
39. Keller MB. Depression: a long-term illness. Br J Psychiatry Suppl 1994;26:9-15.
40. Licht-Strunk E, Van Marwijk HW, Hoekstra T, Twisk JW, De Haan M, Beekman AT. Outcome of depression in later life in primary care: longitudinal cohort study with three years' follow-up. BMJ 2009;338:a3079.
41. Seedat S, Scott KM, Angermeyer MC et al. Cross-national associations between gender and mental disorders in the World Health Organization Mental Health Surveys. Arch Gen Psychiatry 2009;66:785-795.
42. Bijl RV, Ravelli A, Van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998;33:587-595.
43. Wittchen HU, Lieb R, Pfister H et al. The waxing and waning of mental disorders: evaluating the stability of syndromes of mental disorders in the population. Compr Psychiatry 2000;2(Suppl. 1):122-132.